Female Wistar rats tested during late proestrus or during pregnancy and ovariectomized rats tested after receiving progesterone or allopregnanolone displayed reduced conflict behavior

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 26, Issue 5, 2002, Pages 839-844

  Molina Hernandez, Miguel ^a   Perez Garcia, Julian ^a   Olivera Lopez, Jorge Ivan ^b  

^a UNIVERSIDAD VERACRUZANA   (Mexico)

^b DEPARTAMENTO DE QUÍMICA   (Mexico)

Author keywords

Conflict behavior; Estrous cycle; Neurosteroids; Pregnancy

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; NEUROSTEROID; PROGESTERONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONFLICT; CONTROLLED STUDY; DIESTRUS; ESTRUS CYCLE; FEMALE; NONHUMAN; OVARIECTOMY; PREGNANCY; PROESTRUS; PUNISHMENT; RAT; REINFORCEMENT;

ANIMALS; CHOICE BEHAVIOR; CONFLICT (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; OVARIECTOMY; PREGNANCY; PREGNANOLONE; PROESTRUS; PROGESTERONE; RATS; RATS, WISTAR;

EID: 0036592261     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(01)00328-1     Document Type: Article

References (59)

1. Akwa Y., Purdy R.H., Koob G.F., Britton K.T. The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat. Behav. Brain Res. 106:1999;119-125.
2. Bitran D., Dowd J.A. Ovarian steroids modify the behavioral and neurochemical responses of the central benzodiazepine receptor. Psychopharmacology. 125:1996;65-73.
3. Bitran D., Hilvers R.J., Kellogg C.K. Anxiolytic effects of 3α-OH-5α[β]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABA-A receptor. Brain Res. 561:1991;157-161.
4. Bitran D., Purdy R.H., Kellogg C.K. Anxiolytic effect of progesterone is associated with increases in cortical allopregnanolone and GABA-A receptor function. Pharmacol., Biochem. Behav. 45:1993;423-428.
5. Bitran D., Shiekh M., Mcleod M. Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABA-A receptors. J. Neuroendocrinol. 7:1995;171-177.
6. Bitran D., Dugan M., Renda P., Ellis R., Folley M. Anxiolytic effects of the neuroactive pregnanolone (3α-OH-5α-pregnan-20-one) after microinjection in the dorsal hippocampus and lateral septum. Brain Res. 850:1999;217-224.
7. Bitran D., Foley M., Audette D., Leslie N., Frye C.A. Activation of peripheral mitochondrial benzodiazepine receptors in the hippocampus stimulates allopregnanolone synthesis and produces anxiolytic-like effects in the rat. Psychopharmacology. 151:2000;64-71.
8. Bless E.P., Mcginnis K.A., Mitchell A.L., Hartwell A., Mitchell J.B. Effects of gonadal steroids on brain stimulation reward in female rats. Behav. Brain Res. 82:1997;235-244.
9. Buckwalter G.J., Stanczyk F.Z., Mccleary C.A., Bluestein B.W., Buckwalter D.K., Rankin K.P., Chang L., Goodwin M.T. Pregnancy, the postpartum, and steroid hormones: effects on cognition and mood. Psychoneuroendocrinology. 24(1):1999;69-84.
10. Canonaco M., Tavolaro R., Maggi A. Steroid hormones and receptors of the GABA-A supramolecular complex: II. Progesterone and estrogen inhibitory effects on the chloride ion channel receptor in different forebrain areas of the female rat. Neuroendocrinology. 57:1993;974-984.
11. Concas A., Mostallino M., Porcu P., Follesa P., Barbaccia M.L., Trabucchi M., Purdy R., Grisenti P., Biggio G. Role of brain allopregnanolone in the plasticity of γ-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery. Proc. Natl. Acad. Sci. USA. 95:1998;13284-13289.
12. Crammer J.L. Premenstrual depression, cortisol and estradiol treatment. Psychol. Med. 16:1986;451-455.
13. Dubrovsky B. The specificity of stress responses to different nocuous stimuli: neurosteroids and depression. Brain Res. Bull. 51:2000;443-455.
14. Fáncsik A., Linn D.M., Tasker J.G. Neurosteroid modulation of GABA IPSCS is phosphorylation dependent. J. Neurosci. 20:2000;3067-3075.
15. Fernandez-Guasti A., Picazo O. Changes in anxiety along the various phases of the oestrus cycle: effect of oestrogen and progesterone. Psychoneuroendocrinology. 17:1992;681-689.
16. Fernandez-Guasti A., Picazo O. Anxiolytic actions of diazepam, but not of buspirone, are influenced by gender and the endocrine stage. Behav. Brain Res. 88:1997;213-218.
17. Fillingim R.B., Ness T.J. Sex-related hormonal influences on pain and analgesic responses. Neurosci. Biobehav. Rev. 24:2000;485-501.
18. Fink G., Summer B.W., Mcqueen J.K., Wilson H., Rosie R. Sex steroid control of mood, mental state and memory. Clin. Exp. Pharmacol. Physiol. 25:1998;764-775.
19. Freeman M.E. The ovarian cycle of the rat. Knobil E., de Neil J. The Physiology of Reproduction. 1988;1893-1928 Raven Press, New York.
20. Griffin L.D., Mellon S.H. Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc. Natl. Acad. Sci. USA. 96:1999;13512-13517.
21. Hansen S. Mechanisms involved in the control of punished responding in mother rats. Horm. Behav. 24:1990;186-197.
22. Hascöet M., Bourin M. Anticonflict effect of alpidem as compared with the benzodiazepine alprazolam in rats. Pharmacol., Biochem. Behav. 56:1997;317-324.
23. Hascöet M., Bourin M., Todd K.G., Coüetoux Du Terre A. Anti-conflict effect of 5HT-1A agonists in rats: a new model for evaluating anxiolytic-like activity. J. Psychopharmacol. 8:1994;227-237.
24. Heath R.G., Guerrero R. Psychotic behavior with evoked septal dysrhythmia: effects of intracerebral acetylcholine and gamma aminobutyric acid. Am. J. Psychiatry. 131:1974;858-862.
25. Hurwitz H.M., Davis H. Depriving rats of food: a reappraisal of two techniques. J. Exp. Anal. Behav. 40:1983;211-213.
26. Lambert J.J., Belelli D., Hill-Venning C., Peters J.A. Neurosteroids and GABA-A receptor function. Trends Pharmacol. Sci. 16:1995;295-303.
27. Le Foll F., Castel H., Louiset E., Vandry H., Cazin L. Multiple modulatory effects of the neuroactive steroid pregnanolone on GABA-A receptor in frog pituitary melanotrophs. J. Physiol. 504:1997;387-400.
28. Leonard L.G. Depression and anxiety disorders during multiple pregnancy and parenthood. J. Obstet. Gynecol. Neonat. Nurs. 27:1998;329-337.
29. MacArthur C. What does postnatal care do for women's health? Lancet. 353:1999;353-354.
30. Maggi A., Perez J. Progesterone and estrogens in rat brain: modulation of GABA (gamma-amino butyric acid) receptor activity. Eur. J. Pharmacol. 103:1984;165-168.
31. Mahesh V.B., Brann D., Hendry L.B. Diverse modes of action of progesterone and its metabolites. J. Steroid Biochem. Mol. Biol. 56:1996;209-219.
32. Maitra R., Reynolds J.N. Subunit dependent modulation of GABA-A receptor function by neuroactive steroids. Brain Res. 819:1999;75-82.
33. Molina M., Téllez N.P. Estrus variation in anticonflict effects of midazolam microinjected into septal nuclei in female Wistar rats. Pharmacol., Biochem. Behav. 68:2001;531-537.
34. Molina M., Contreras C.M., Telléz P. Antidepressant-like effects of pregnancy and progesterone in Wistar rats as measured in the differential reinforcement of the low-rate 72s task. Psychopharmacology. 151:2000;306-311.
35. Molina M., Contreras C.M., Téllez N.P. Diazepam increases the number of punished responses in a conflict-operant paradigm during late proestrus and estrus in the Wistar rat. Neuropsychobiology. 43:2001;29-33.
36. Mora S., Dussaubat N., Diaz-Veliz G. Effects of the estrus cycle and ovarian hormones on behavioral indices of anxiety in female rats. Psychoneuroendocrinology. 21:1996;609-620.
37. National Institutes of Health Guide for the Care and Use of Laboratory Animals. 1996;National Institutes of Health, National Academy Press, Washington, DC.
38. Neumann I.D., Wigger A., Liebsch G., Holsboer F., Landgraf R. Increased basal activity of the hypothalamo-pituitary-adrenal axis during pregnancy in rats bred for high anxiety-related behavior. Psychoneuroendocrinology. 23:1998;449-463.
39. Neumann I.D., Johnstone H.A., Hatzinger M., Liebsch G., Shipston M., Russell J.A., Landgraf R., Douglas A.J. Attenuated neuroendocrine responses to emotional and physical stressors in pregnant rats involve adenohypophysial changes. J. Physiol. 508:1998;289-300.
40. Patchev V.K., Shoaib M., Holsboer F., Almeida O.F.X. The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus. Neuroscience. 62:1994;265-271.
41. Petty F. GABA and mood disorders: a brief review and hypothesis. J. Affective Disord. 34:1995;275-281.
42. Picazo O., Fernandez-Guasti A. Changes in experimental anxiety along pregnancy and lactation. Physiol. Behav. 54:1993;295-299.
43. Picazo O., Fernandez-Guasti A. Anti-anxiety effects of progesterone and some of its reduced metabolites: an evaluation using the burying behavior test. Brain Res. 680:1995;135-141.
44. Picazo O., Fernandez-Guasti A., Lemus A.E., Garcia G.A. A-ring reduced derivatives of two synthetic progestins induce anxiolytic effects in ovariectomized rats. Brain Res. 796:1998;45-52.
45. Rodriguez J.F., Howard J.L., Pollard G.T., Hendricks S.E. Effect of ovarian hormones on conflict behaviour. Psychoneuroendocrinology. 9:1984;293-300.
46. Rodriguez J.F., Hagley M.T., Hendricks S.E. Anxiolytic effects of progesterone are sexually dimorphic. Life Sci. 38:1986;1841-1845.
47. Romeo E., Strohle A., Spalletta G., Di Michele F., Hermann B., Holsboer F., Pasini A., Rupprecht R. Effects of antidepressant treatment on neuroactive steroids in major depression. Am. J. Psychiatry. 155:1998;910-913.
48. Schmidt P.J., Rubinow D.R. Neuroregulatory role of gonadal steroids in humans. Psychopharmacol. Bull. 33:1997;219-220.
49. Shekhar A., Keim S.R. The circumventricular organs form a potential neural pathway for lactate sensitivity: implications for panic disorder. J. Neurosci. 17:1997;9726-9735.
50. Shen W., Mennerick S., Covey D.F., Zorumski C.F. Pregnanolone sulfate modulates inhibitory synaptic transmission by enhancing GABA-A receptor desensitization. J. Neurosci. 20:2000;3571-3579.
51. Ströhle A., Pasini A., Romeo E., Hermann B., Spalletta G., Di Michele F., Holsboer F., Rupprecht R. Fluoxetine decreases concentrations of 3α, 5β-tetrahydrodeoxycorticosterone (THDOC) in major depression. J. Psychiatr. Res. 34:2000;183-186.
52. Stuart S., Couser G., Schilder K., Ohara M.W., Gorman L. Postpartum anxiety depression: onset and comorbidity in a community sample. J. Nerv. Ment. Dis. 186:1998;420-424.
53. Twyman R.E., Macdonald R.L. Neurosteroid regulation of GABA-A receptor single-channel kinetic properties of mouse spinal cord neurons in culture. Physiol. Behav. 456:1992;215-245.
54. Uzunov D.P., Cooper T.B., Costa E., Guidotti A. Fluoxetine-induced changes in brain neurosteroid content measured by negative ion mass fragmentography. Proc. Natl. Acad. Sci. USA. 93:1996;12599-12604.
55. Uzunova V., Sheline Y., Davis J.M., Rasmusson A., Uzunov D.P., Costa E., Guidotti A. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc. Natl. Acad. Sci. USA. 95:1998;3239-3244.
56. Vivian J.A., Barros H., Manitiu A., Miczek K.A. Ultrasonic vocalizations in rat pups: modulation at the γ-aminobutyric acid A receptor complex and the neurosteroid recognition site. J. Pharmacol. Exp. Ther. 282:1997;318-325.
57. Wagner K.D., Berenson A.B. Norplant-associated major depression and panic disorder. J. Clin. Psychiatry. 55:1994;478-480.
58. Wieland S., Lan N.C., Mirasedeghi S., Gee K.W. Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-OH-20-one. Brain Res. 565:1991;263-268.
59. Zhu W., Vicini S. Neurosteroids prolong GABA-A channel deactivation by altering kinetics of desensitized states. J. Neurosci. 17:1997;4022-4031.